


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
ALVO
Alvotech
$4.14
ALVO Price Performance
$5.33 (-22.33%)
$5.34 (-22.47%)
$8.4 (-50.71%)
$10.7 (-61.31%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
ALVO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ALVO Street Sentiment is extremely bullish and have negative views on the near-term outlook
ALVO has Medium risk level
Risk Indicators
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Nov 19, 2025
Reiterate
Buy
UBS
CHRS
Coherus BioSciences
1.63
-4.68%
BIIB
Biogen
192.03
-0.03%
AMGN
Amgen
374.75
-0.20%
What is ALVO current stock price?
What are ALVO stock strengths?
What is ALVO Risk Level?
What is ALVO market cap and volume?
What is ALVO current Stock IQ?
Should I buy ALVO stock right now?
Is ALVO a Strong Buy right now?
What does a 'Strong Buy' rating mean for ALVO?
What does a 'Strong Sell' rating mean for ALVO?
What factors influence ALVO's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
ALVO
Alvotech
Current Price
$4.14
Runners Also Watch
CHRS
Coherus BioSciences
1.63
-4.68%
BIIB
Biogen
192.03
-0.03%
AMGN
Amgen
374.75
-0.20%

ALVO Price Performance
$5.33 (-22.33%)
$5.34 (-22.47%)
$8.4 (-50.71%)
$10.7 (-61.31%)
ALVO Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
ALVO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ALVO Street Sentiment is extremely bullish and have negative views on the near-term outlook
ALVO has Medium risk level
Risk Indicators
Average key support and resistance price levels
Overall Wall Street Rating
ALVO Stock IQ
Stock Insights
Not Enough Information
ALVO Latest Analysis
Alvotech Enters Oversold Territory (ALVO). Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me
Wed Feb 18, 2026
Alvotech Reports Positive Top-line Pharmacokinetic Study Results For AVT80 A Biosimilar To Entyvio . (RTTNews) - Alvotech (ALVO) has reported that its pivotal pharmacokinetic study for AVT80- its proposed biosimilar to Takeda Pharmas Entyvio - met all primary endpoints marking a key milestone in the companys dual-formulation vedolizumab program.
Thu Feb 5, 2026
Alvotech higher on positive data backing biosimilar to Takedas Entyvio.
Thu Feb 5, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ALVO Stock trends
ALVO Stock performance
ALVO Stock analysis
ALVO investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.